Technology serving the patient: How secondary pharma packaging is evolving with a customer centric mindset

Once seen as a purely logistical tool, pharmaceutical secondary packaging has evolved far beyond its traditional role. Today’s packaging solutions serve as a strategic interface that directly impacts patient outcomes, creating enhanced connections between manufacturers, patients, and healthcare professionals.  

This paradigm shift is being driven in part by changing expectations. Patients now expect packaging to be easy to open, informative, and supportive of their daily routines. Packaging succeeds if it fits into their lifestyle without disruption, helping them manage their treatments at home. Healthcare professionals want packaging to facilitate correct administration and reduce medication errors, streamline workflows, support adherence, and integrate with digital health records or monitoring systems. 

In this landscape, creating customer centric packaging means more than meeting regulatory requirements, or providing protection against tampering. Successful pharmaceutical packaging anticipates the needs of those who use it, providing a touchpoint to information, reassurance, and tools that enhance patient outcomes. 

The evolution of secondary pharmaceutical packaging is fundamentally rooted in putting the user at the centre of every design and technological decision. While regulatory compliance remains a foundational requirement, the most forward thinking packaging solutions now go further, proactively anticipating the needs, preferences, and concerns of those who ultimately rely on these products. Customer centric packaging is not satisfied with simply meeting legal standards for safety and traceability. Instead, it seeks to foster trust and confidence by providing clear, accessible authentication features that are meaningful to patients and caregivers. 

With the growing risk posed by counterfeit medicines, technologies that can help to build trust and protect product integrity are invaluable assets for any pharmaceutical company. In particular, advanced tracking systems are increasingly being leveraged to offer patients and healthcare professionals unprecedented visibility into their medicines. Unique GS1 Datamatrix identifiers, overt and covert features, and multi-factor verification systems are being integrated into packaging to provide end to end traceability and rapid recall capabilities. 

Similarly, smart labels incorporating UHF RFID (Ultra High Frequency Radio Frequency Identification) technology are becoming increasingly common among pharmaceutical companies looking to bolster traceability and authenticity. These smart tags enable accurate, real time tracking of products, reducing errors and ensuring that medicines are stored and dispensed under optimal conditions. 

Standardised gs1 variable 1D and 2D codes and near field communication (NFC) tags are also being used to transform packaging into a digital touchpoint. Patients and healthcare providers can instantly access up to date product information, instructional content, adverse event reporting portals, and even personalised adherence support. The ability to tailor content based on patient demographics, language, or therapeutic context is enhancing engagement and reducing barriers to effective therapy. 

For the patient, the value is clear: protection from counterfeit products, better access to data regarding the origin and handling of their medication, and strengthened trust in both the brand and the safety of their treatment.   

The true test of customer centric packaging lies in its ability to directly support the patient. Innovative, active, and connected packaging solutions are increasingly being designed to transform packaging, turning from a passive container into an active part of delivering treatments. 

Visual indicators can offer additional benefits for empowering patients to manage their own care. Time temperature indicators (TTIs) and colour change labels both provide powerful tools for determining whether medication has been stored correctly or is nearing expiry. Using them reduces the risk of medicines being compromised, reassuring patients about the efficacy of their treatment. 

Augmented reality (AR) and NFC-enabled packaging are also opening new horizons for patient education and engagement. By simply scanning the packaging with a smartphone, patients can access interactive instructions or even demonstration videos. For those managing chronic conditions or complex treatment regimes, these innovations can make the difference between successful treatments and avoidable complications. 

The successful deployment of such advanced packaging solutions is not necessarily straightforward. Integration requires a holistic approach that prioritises innovation with operational excellence and regulatory rigour. 

Digital quality control systems offer one pathway to striking the required balance for successful implementation. The integration of digital inspection systems, machine vision, and real time data analytics is elevating quality assurance in packaging lines. These technologies ensure that secondary packaging is manufactured to the highest standards of accuracy and consistency, with data integrity and security feature placement a priority.   

For pharmaceutical manufacturers, the challenge lies in scaling these projects to commercial production without compromising efficiency, cost, or compliance. This necessitates close collaboration with packaging partners, technology providers, and regulatory bodies to ensure that any innovations are scalable and ready for real world integration. This results in packaging solutions that deliver on enhancing patient safety and supporting healthcare professionals. 

The ongoing digital transformation in the pharmaceutical industry means that secondary packaging will only play an increasingly central role going forward. The convergence of technology, empathy, and operational excellence is redefining what it means to be customer centric, with modern packaging designed to shape patient experiences and safeguard public health. 

MM Packaging is committed to partnering with the industry to deliver technologically advanced solutions that are attuned to patient needs. By integrating smart, connected solutions into the fabric of pharmaceutical supply chains, the company is helping build a future where packaging can have a lasting impact on safe, effective, and patient centric healthcare.